Emerging Options in Second-Line Therapy for Metastatic NSCLC
Dr Tom Stinchcombe of Duke University in Durham, North Carolina, discusses ADCs, checkpoint inhibitors combined with tumor treating fields (TTF) therapy, and other targeted therapies being evaluated as second-ling therapies for metastatic NSCLC.
Dr Stinchcombe first describes telisotuzumab vedotin, a c-Met-directed antibody and microtubule inhibitor conjugate indicated for metastatic NSCLC patients with high c-Met protein overexpression. The drug received FDA-accelerated approval on the basis of the LUMINOSITY trial, in which telisotuzumab vedotin monotherapy provided clinically meaningful response and progression-free survival in this population.
He then describes TTF therapy, which delivers electrical impulses to the tumor site to disrupt processes critical for cancer cell division.
The LUNAR trial showed the benefit of TTF plus checkpoint inhibition in second-line treatment of metastatic NSCLC, suggesting an additive benefit of this combination.
Finally, he discussed two trials showing second-line therapies for patients with KRAS G12C mutations, in which sotorasib and adagrasib have shown potential benefit over docetaxel in this population.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
SpaceX is set to launch from Cape Canaveral on Monday
SpaceX plans a Falcon 9 launch of the SESO3b mPOWERmission rocket from Cape Canaveral Space Force Station on Monday afternoon. The launch window for the SpaceX mission opens Monday AT 5:12 p.m. and will remain open for two hours. In case of any delays or issues, a backup launch window is available on Tuesday at the same time. SpaceX Said this will be the sixth flight for the first stage booster supporting this mission. Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live. Solve the daily Crossword
Medscape
an hour ago
- Medscape
Breast Growth: Cancer or Coincidence in 42-Year-Old?
A 42-year-old woman presented with an atypical enlarging breast mass over the course, which initially raised suspicion of a serious condition but resolved spontaneously. Initial physical examination revealed skin ulcerations and nipple retraction, raising suspicion for inflammatory breast cancer. Biopsy revealed acute and chronic inflammation, granulation-type tissue, and focal granuloma with suppuration, but no evidence of malignancy. With the diagnosis still unclear, the patient was asked to return within 1 month. However, upon her return, the breast mass and positive axillary lymph node had decreased in size significantly, with ulcerated areas showing signs of healing. The case reported by Junisha Martin, a medical student at Ross University School of Medicine in Miami, highlighted the importance of considering a wide range of potential diagnoses. The Patient and Her History The patient with no significant past medical history presented with an enlarging 4.5 cm mass over 2.5 months in the right breast. The patient disclosed that 2 years ago, she had experienced a lemon-sized lump in her right breast that had persisted for approximately 2 months. The mass was accompanied by small superficial ulcerations on the overlying skin and occasional discomfort. The mass completely resolved during that time, and no medical treatment was sought. Six months later, the mass returned to the same location and increased in size, with ulcerations in the areolar region. The patient declined to undergo mammography during that time because of the discomfort of the areolar lesion. The past surgical history consisted of three prior caesarean sections. The patient denied any allergies, smoking, recent travel, pets at home, or use of topical creams and ointments on the affected area. The patient denied any significant family or social history. Findings and Diagnosis On admission, patient vitals were obtained and reported normal: temperature 36.8 °C, blood pressure 132/88 mm Hg, heart rate 84 beats/min, respiratory rate 19 breaths/min, and oxygen saturation 99% on room air. She was alert and in no acute distress on physical examination. Physical examination revealed that the large right breast mass had decreased in size significantly. The mass now measured 3 cm from 4.5 cm and was non-tender, with minimal nipple retraction and healing ulcerations and scars with improving skin discoloration. The patient was scheduled for an ultrasound-guided core biopsy of the right breast and right axillary lymph node due to a high suspicion of malignancy, instead of fine-needle aspiration cytology. A core biopsy of the right breast at 12:00 revealed acute and chronic inflammation, granulation-type tissue, and focal granuloma with suppuration. Immunohistochemical tests were negative for carcinoma. A right axillary lymph node biopsy revealed sinus histiocytosis and acute non-specific lymphadenitis but no evidence of malignancy. During the follow-up visit after 1 week, the patient reported feeling well, with mild soreness at the biopsy site. Repeated physical examinations were consistent with an enlarging areolar breast mass with skin ulcerations and nipple retraction. The right breast was moderately tender on palpation. Due to the discordance between the pathology report and physical examination, a repeat ultrasound-guided biopsy was recommended for further management. No medications were prescribed to the patient, and conservative measures were taken because the final diagnosis was not confirmed. Upon repeat biopsy, physical examination revealed that the large right breast mass had decreased in size significantly. The decreasing size of the lesion (mass effect), decreasing size of the lymph node, and the nature of the ulcer now healing ruled out inflammatory breast cancer, and the physician suspected an idiopathic aetiology, instead of an inflammatory or infectious cause of this patient's presentation. A multidisciplinary approach was established for the patient, with a primary care physician and surgeon for further management if there were signs of disease progression. Discussion 'This case illustrates the diagnostic challenges of inflammatory breast lesions with overlapping clinical presentations. While initial findings suggested inflammatory breast cancer, biopsy results were negative for malignancy, pointing towards a benign inflammatory or infectious aetiology, such as idiopathic granulomatous mastitis or cat scratch disease. The spontaneous improvement after conservative management provided further evidence against a malignant process. This case reinforces the need for interdisciplinary collaboration, and further research into inflammatory breast pathologies is vital. Maintaining an open perspective and integrating all available data are essential when evaluating breast masses, facilitating timely diagnosis, and preventing unnecessary aggressive treatments. This case concluded without a definitive diagnosis, highlighting the importance of flexible management guided by clinical improvement in complex presentations,' the authors wrote.
Yahoo
2 hours ago
- Yahoo
Study reveals this type of exercise lowers your biological age by 9 years
When you buy through links on our articles, Future and its syndication partners may earn a commission. If you're looking to pause time, we've got good news — when it comes to biological aging, that's the aging process that happens inside your cells, sweating can help. Specifically, sweating due to high-impact exercise, which can lower your biological age by nearly a decade, according to researchers. The study, conducted at Brigham Young University and published in the Preventive Medicine medical journal, looked at the data of more than 5,800 adults aged 20-84. The study looked at the participants' biological age by examining the length of their telomeres — these are the protective DNA caps at the end of chromosomes. Telomeres prevent your DNA from getting damaged; they shorten as we get older, and shortened telomeres are often associated with age-related diseases. The measurement is taken through blood samples. The researchers found that people who consistently performed high levels of physical activity, specifically high-impact activity, had longer telomeres than those with sedentary lifestyles. For the study, to be highly active, women had to engage in 30 minutes of jogging per day and 40 minutes for men, five days a week. They concluded that regular high-impact exercise added nine years of reduced cellular aging. 'If you want to see a real difference in slowing your biological aging, it appears that a little exercise won't cut it,' exercise science professor Larry Tucker said. 'You have to work out regularly at high levels.' If you're new to jogging, it can be difficult to know where to start. Mixing jogging with walking intervals as you get fitter and build up your distance, also known as Jeffing, can be beneficial. Here's everything you need to know about Jeffing, and a round-up of the best running shoes on the market. That said, if you're not a runner or you're worried about the impact of running on your joints, high-intensity training doesn't have to involve pounding the sidewalk or hours on the treadmill. HIIT training, cycling sprints on a stationary bike, taking a spin class, or using the rowing machine in the gym all count as high-intensity exercise. Find the one that works for you, and you'll increase your cardiovascular fitness while lowering your biological age. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide Forget running and swimming — study finds this sport adds 10 years to your life Forget gym machines — study shows this type of exercise is the most effective at building strength, muscle and power Forget 10,000 steps — study reveals the real number of minimum daily steps you should take, according to your age
